Claim(permalink)
Roche ha ritirato il certificato di registrazione del MabThera, farmaco che sarebbe usato per il trattamento di linfoma non-Hodgkin, leucemia linfatica cronica, artrite reumatoide e granulomatosi
✓facta rating: not verifiable; published on 2023-09-04
Factors
veracity
not verifiable
Political Leaning
left political leaning
Sentiment
neutral sentiment
Date published
2023-09-04
Entities
MarsPerdita Hyde-SinclairRepublican National CommitteeAncoraSwitzerlandPrefectures of GreeceHanno the NavigatorWhatsAppRussiaFacebookCreative Commons licenseWikimedia CommonsRTVIRituximabRiga